Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner.

@article{Cho2007CordycepinI,
  title={Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner.},
  author={Hyun-Jeong Cho and Jae Youl Cho and Man Hee Rhee and Hwa-Jin Park},
  journal={European journal of pharmacology},
  year={2007},
  volume={558 1-3},
  pages={
          43-51
        }
}
Cordycepin (3'-deoxyadenosine) is isolated from Cordyceps militaris, a species of the fungal genus Cordyceps. Cordycepin is an ingredient used in traditional Chinese medicine and is prescribed for various diseases, such as cancer and chronic inflammation. In this study, we investigated the novel effect of cordycepin (3'-deoxyadenosine) on collagen-induced human platelet aggregation. Cordycepin inhibited dose-dependently collagen-induced platelet aggregation in the presence of various… Expand
Epigallocatechin-3-gallate has an anti-platelet effect in a cyclic AMP-dependent manner.
TLDR
It is demonstrated that EGCG increases cAMP via adenylate cyclase activation and subsequently phosphorylates VASP-Ser(157) through A-kinase activation to inhibit [Ca(2+) mobilization and TXA(2) production on collagen-induced platelet aggregation. Expand
Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro
TLDR
It is suggested that cordycepin-enriched WIB-801CE has therapeutic potential to treat platelet activation-mediated thrombotic diseases in vivo and in vivo. Expand
Antiplatelet Effects of Cordycepin-Enriched WIB-801CE from Cordyceps militaris: Involvement of Thromboxane A2, Serotonin, Cyclooxygenase-1, Thromboxane A2 Synthase, Cytosolic Phospholipase A2
TLDR
Data suggest that cordycepin-enriched WIB-801CE may be a beneficial component against protection from platelet aggregation-mediated thrombotic disease. Expand
Cordycepin attenuates neointimal formation by inhibiting reactive oxygen species-mediated responses in vascular smooth muscle cells in rats.
TLDR
It is demonstrated that cordycepin may exert inhibitory effects on PDGF-BB-induced migration and proliferation via interfering with adenosine receptor-mediated NOS pathways, thus resulting in the attenuation of neointima formation. Expand
Cordycepin-Enriched WIB801C from Cordyceps militaris Inhibits Collagen-Induced [Ca2+]i Mobilization via cAMP-Dependent Phosphorylation of Inositol 1, 4, 5-Trisphosphate Receptor in Human Platelets
TLDR
It is demonstrated that CE-WIB801C with cAMP-dependent Ca2+-antagonistic antiplatelet effects may have preventive or therapeutic potential for platelet aggregation-mediated diseases, such as thrombosis, myocardial infarction, atherosclerosis, and ischemic cerebrovascular disease. Expand
Cordycepin-enriched WIB801C from Cordyceps militaris inhibits ADP-induced [Ca2+]i mobilization and fibrinogen binding via phosphorylation of IP3R and VASP
TLDR
It is demonstrated that CE-WIB801C may have a preventive or therapeutic potential for platelet aggregation-mediated diseases, such as thrombosis, myocardial infarction, atherosclerosis, and ischemic cerebrovascular disease. Expand
Ex vivo and in vivo studies of CME-1, a novel polysaccharide purified from the mycelia of Cordyceps sinensis that inhibits human platelet activation by activating adenylate cyclase/cyclic AMP.
TLDR
This study demonstrates for the first time that CME-1 exhibits highly potent antiplatelet activity that may initially activate adenylate cyclase/cyclic AMP and, subsequently, inhibit intracellular signals (such as Akt and MAPKs), ultimately inhibiting platelet activation. Expand
Cordycepin-enriched WIB801C from Cordyceps militaris inhibits ADP-induced (Ca 2+ ) i mobilization and fibrinogen binding via phosphorylation of IP3R and VASP
TLDR
It is demonstrated that CE-WIB801C may have a preventive or therapeutic potential for platelet aggregation-mediated diseases, such as thrombosis, myocardial infarction, atherosclerosis, and ischemic cerebrovascular disease. Expand
N1-(Quinolin-2-ylmethyl) butane-1, 4-diamine, a polyamine analog: inhibition of platelet aggregation mediated by an elevated VASP, and decreased MAPK phosphorylation
  • Yuan-yuan Gao, Bian-Sheng Ji
  • Chemistry, Medicine
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
  • 2014
TLDR
QMA inhibited thrombin-induced platelet aggregation ex vivo, and has a strong antiplatelet potential via its multitarget mechanism. Expand
Effect of Cordycepin-Enriched WIB801C from Cordyceps militaris Suppressing Fibrinogen Binding to Glycoprotein IIb/IIIa
TLDR
The results strongly indicate that CE-WIB801C and cordycepin may have preventive or therapeutic potential for platelet aggregation-mediated diseases, such as thrombosis, myocardial infarction, atherosclerosis, and ischemic cerebrovascular disease. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 41 REFERENCES
Inhibitory Effect of Cordycepin on Human Platelet Aggregation
Cordycepin separated from Cordyceps militaris is a major physiologic active component in Cordyceps militaris. The platelet aggregation is stimulated by Ca²?, which is either mobilized fromExpand
Inhibition of platelet function by A02131-1, a novel inhibitor of cGMP-specific phosphodiesterase, in vitro and in vivo.
TLDR
Data indicate that A02131-1 is a cGMP-specific PDE (type V) inhibitor in human platelets and was clearly shown to be more effective than dipyridamole in prolonging the tail bleeding time of conscious mice. Expand
In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
TLDR
In conclusion, picotamide inhibits the TxA2/PE-dependent platelet responses to agonists by a double mechanism: (i), T xA 2/PE antagonism; (ii) inhibition of thromboxane synthase. Expand
Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
TLDR
GBH consists of the 5 herbs Cinnamomi Ramulus, Poria Cocos, Mountan Cortex Radicis, Paeoniae Radix, and Persicae Semen, which have been used in herbal medicine for thousands of years for atherosclerosis and may provide a good tool for investigating Ca2+ mobilization. Expand
Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate
TLDR
Inhibition of rat platelet aggregation by MAHMA NONOate (like GSNO) is largely ODQ‐resistant and, by implication, independent of soluble guanylate cyclase. Expand
Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation.
TLDR
It is proposed that the uncharged derivatives of a 2-chloro-N(6)-methyladenine-9-(2-methylpropyl) scaffold, containing uncharged substitutions of the phosphate groups, are acting as antagonists of a parallel pro-aggregatory receptor present on platelets, that is, the P2Y(12) receptor. Expand
Inhibitory effects of cordycepin on cyclic nucleotide-dependent and cyclic nucleotide-independent protein kinases
TLDR
The inhibitory effect of cordycepin was competitive with respect to ATP in all cases, and the K m for ATP was increased 3-fold and 5-fold by 5 × 10 −4 M cordYcepin for G-PK and A-PK, respectively. Expand
Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen‐induced platelet aggregation by nitroprusside *
TLDR
Human platelet cGMP‐dependent protein kinase (PKG) coelectrophoresed with the purified bovine type Iβ isoenzyme showed that both PKG and cAMP participate in the inhibition of collagen‐induced platelet aggregation by NP, suggesting that an optimal inhibitory effect of NP requires simultaneous activation of both enzymes. Expand
Nitroprusside in vitro inhibits platelet aggregation and intracellular calcium translocation. Effect of haemoglobin.
TLDR
The hypothesis may be suggested that nitroprusside inhibits platelet functions by mimicking the endogenous NO, and that the intracellular calcium metabolism is involved in the inhibitory activity of the drug. Expand
Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect.
TLDR
Adenosine, which enhances intraplatelet cAMP levels, was determined to also cause an increase in cGMP concentrations through a mechanism that involves NO synthesis. Expand
...
1
2
3
4
5
...